Vascular density and VEGF expression in hepatic lesions

Area of Science:

• Oncology
• Hepatology
• Angiogenesis Research

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally, characterized by high vascularity.
• Vascular Endothelial Growth Factor (VEGF) is implicated in HCC survival, but its role in vascular density within HCC and cirrhotic tissue is unclear.

Purpose of the Study:

• To investigate the relationship between VEGF expression and vascular density in normal liver, cirrhotic liver, and HCC.
• To quantify vascularization differences in these liver conditions using advanced imaging analysis.

Main Methods:

• Utilized computer-based analysis of immunohistochemical stainings to assess VEGF expression and vascular density.
• Examined normal hepatic parenchyma, cirrhotic tissue, and HCC samples.
• Confirmed findings using Western Blot analysis.

Main Results:

• Significantly increased vascular density was observed in HCC (185%) and fibrotic cirrhotic tissue (146%) compared to non-neoplastic liver.
• Cirrhotic nodules showed reduced vascularization (71%) relative to normal liver.
• A strong positive correlation (r=0.98) was found between VEGF expression levels and vessel count.

Conclusions:

• Hepatocellular carcinoma and cirrhosis exhibit distinct vascularization patterns, quantifiable by computer-assisted analysis.
• VEGF appears to be a key driver of angiogenesis in these liver conditions, with elevated expression in HCC and reduced levels in cirrhotic nodules.
• Angiogenesis, influenced by VEGF, likely plays a critical role in the pathogenesis of cirrhosis and HCC.